Our Services
Medical Information
Helpful Resources
Published on: 9/13/2026
Yes, ADHD symptoms in women often intensify during perimenopause and in the late luteal phase just before menstruation, when estrogen drops and dopamine activity falls with it. Many women report worse focus, memory lapses, brain fog, emotional dysregulation, and reduced medication effectiveness at these times, and some are diagnosed for the first time in their 40s or 50s because hormonal shifts unmask lifelong traits. Because these changes can overlap with anxiety, depression, thyroid problems, and typical menopause symptoms, there are several important factors to consider, including cycle tracking, dosage timing, and hormone therapy, all explained more fully below.
If your focus, mood, or memory seems to swing with your cycle or has changed sharply in midlife, a free, instant, online symptom check can help you sort out which symptoms point to ADHD, which may be hormonal, and which deserve other testing. It takes only a few minutes, is available any time without an appointment, and gives you a clearer summary of possible causes and next steps to bring to your doctor so your concerns are taken seriously rather than dismissed as stress.
Last reviewed for medical accuracy: 09/13/2026
Understanding ADHD, Hormones, and Women’s Health
Attention-Deficit/Hyperactivity Disorder (ADHD) affects people of all genders, but women often face unique challenges. Fluctuating hormone levels—both monthly and over the long term—can influence ADHD symptoms like inattention, impulsivity, and mood swings. Two key hormonal transitions to consider are:
Research from organizations such as the National Institute of Mental Health (NIMH), CHADD (Children and Adults with Attention-Deficit/Hyperactivity Disorder), and the American Psychological Association indicates that estrogen and progesterone play roles in brain chemistry and executive function. When these hormones dip or fluctuate, ADHD symptoms can intensify.
Many women with ADHD notice a “roller-coaster” of symptoms in the week or so before their period. Here’s why:
Common premenstrual ADHD flare-ups:
What you can do:
Perimenopause typically begins in the mid-40s but can start earlier. It may last several years before periods stop completely. Hormone levels swing unpredictably:
These fluctuations can significantly affect ADHD:
Key points from clinicians:
While you can’t stop hormonal changes, you can reduce their impact on ADHD:
Consistent Routine
Nutrition and Supplements
Exercise and Movement
Stress Management
Sleep Hygiene
Medication and Therapy
It’s helpful to regularly check in on how your body and mind are responding. If you’d like a structured assessment, try a free, online symptom check, using the doctor approved Ubie Symptom Checker. This tool can help you:
While mood dips and focus issues around your cycle or during perimenopause are common for women with ADHD, some situations warrant prompt medical attention:
Always speak to a doctor about anything life threatening or serious. Your healthcare team can tailor treatments—whether adjusting ADHD medications, exploring hormonal therapies, or providing mental health support—to fit your unique needs.
Key Takeaways
(References)
* Dorani F, Bijlenga D, Beekman ATF, van Someren EJW, Kooij JJS. Prevalence of hormone-related mood disorder symptoms in women with ADHD. J Psychiatr Res. 2021 Jan;133:10-15. doi: 10.1016/j.jpsychires.2020.12.005. Epub 2020 Dec 3. PMID: 33302160.
* Eng AG, Nirjar U, Elkins AR, Sizemore YJ, Monticello KN, Petersen MK, Miller SA, Barone J, Eisenlohr-Moul TA, Martel MM. Attention-deficit/hyperactivity disorder and the menstrual cycle: Theory and evidence. Horm Behav. 2024 Feb;158:105466. doi: 10.1016/j.yhbeh.2023.105466. Epub 2023 Nov 30. PMID: 38039899; PMCID: PMC10872410.
* de Jong M, Wynchank DSMR, van Andel E, Beekman ATF, Kooij JJS. Female-specific pharmacotherapy in ADHD: premenstrual adjustment of psychostimulant dosage. Front Psychiatry. 2023;14:1306194. doi: 10.3389/fpsyt.2023.1306194. Epub 2023 Dec 13. PMID: 38152361; PMCID: PMC10751335.
* Craddock E. Being a Woman Is 100% Significant to My Experiences of Attention Deficit Hyperactivity Disorder and Autism: Exploring the Gendered Implications of an Adulthood Combined Autism and Attention Deficit Hyperactivity Disorder Diagnosis. Qual Health Res. 2024 Dec;34(14):1442-1455. doi: 10.1177/10497323241253412. Epub 2024 Jul 18. PMID: 39025117; PMCID: PMC11580322.
* Osianlis E, Thomas EHX, Jenkins LM, Gurvich C. ADHD and Sex Hormones in Females: A Systematic Review. J Atten Disord. 2025 Jul;29(9):706-723. doi: 10.1177/10870547251332319. Epub 2025 Apr 18. PMID: 40251875; PMCID: PMC12145478.
* Kooij JJS, de Jong M, Agnew-Blais J, Amoretti S, Bang Madsen K, Barclay I, Bölte S, Borg Skoglund C, Broughton T, Carucci S, van Dijken DKE, Ernst J, French B, Frick MA, Galera C, Groenman AP, Kopp Kallner H, Kerner Auch Koerner J, Kittel-Schneider S, Manor I, Martin J, Matera E, Parlatini V, Philipsen A, Ramos-Quiroga JA, Rapoport IL, Remnélius KL, Sénéquier A, Thorell L, Wittekoek JME, Wynchank D. Research advances and future directions in female ADHD: the lifelong interplay of hormonal fluctuations with mood, cognition, and disease. Front Glob Womens Health. 2025;6:1613628. doi: 10.3389/fgwh.2025.1613628. Epub 2025 Jul 7. PMID: 40692967; PMCID: PMC12277363.
* Jakobsdóttir Smári U, Valdimarsdottir UA, Wynchank D, de Jong M, Aspelund T, Hauksdottir A, Thordardottir EB, Tomasson G, Jakobsdottir J, Lu D, Nevriana A, Larsson H, Kooij S, Zoega H. Perimenopausal symptoms in women with and without ADHD: A population-based cohort study. Eur Psychiatry. 2025 Sep 4;68(1):e133. doi: 10.1192/j.eurpsy.2025.10101. Epub 2025 Sep 4. PMID: 40903825; PMCID: PMC12538516.
* Krebs K, Donnellan-Fernandez R. Integrative literature review - the impact of ADHD across women's lifespan. BMC Womens Health. 2025 Dec 8;25(1):593. doi: 10.1186/s12905-025-04123-1. Epub 2025 Dec 8. PMID: 41361438; PMCID: PMC12683802.
* Wynchank D, Sutrisno RMGTMF, van Andel E, Kooij JJS. Menstrual Cycle-Related Hormonal Fluctuations in ADHD: Effect on Cognitive Functioning-A Narrative Review. J Clin Med. 2025 Dec 24;15(1). doi: 10.3390/jcm15010121. Epub 2025 Dec 24. PMID: 41517370; PMCID: PMC12786913.
* Wynchank D, Kooij S. Pharmacological Management of ADHD in Women Across Perimenopause, Menopause and Post-Menopause. Drugs Aging. 2026 May;43(5):385-395. doi: 10.1007/s40266-026-01291-z. Epub 2026 Apr 22. PMID: 42018215; PMCID: PMC13149623.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.